PZ Cussons Stock Rating Reaffirmed by Canaccord Genuity (PZC)
PZ Cussons (LON:PZC)‘s stock had its “buy” rating restated by equities researchers at Canaccord Genuity in a research report issued on Tuesday, Analyst Ratings.Net reports. They currently have a GBX 440 ($7.22) price objective on the stock. Canaccord Genuity’s target price indicates a potential upside of 17.33% from the stock’s previous close.
PZC has been the subject of a number of other recent research reports. Analysts at Investec cut their price target on shares of PZ Cussons from GBX 441 ($7.23) to GBX 400 ($6.56) in a research note to investors on Thursday, December 12th. They now have a “hold” rating on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of PZ Cussons in a research note to investors on Wednesday, December 11th. They now have a GBX 390 ($6.40) price target on the stock. Finally, analysts at Panmure Gordon reiterated a “buy” rating on shares of PZ Cussons in a research note to investors on Wednesday, December 11th. They now have a GBX 445 ($7.30) price target on the stock. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of GBX 420.50 ($6.90).
Shares of PZ Cussons (LON:PZC) traded down 0.56% on Tuesday, hitting GBX 375.00. The stock had a trading volume of 119,034 shares. PZ Cussons has a 1-year low of GBX 335.00 and a 1-year high of GBX 439.50. The stock’s 50-day moving average is GBX 376.7 and its 200-day moving average is GBX 392.. The company’s market cap is £1.593 billion.
PZ Cussons Plc is a holding company. The Company is engaged in the manufacture and distribution of soaps, detergents, toiletries, beauty products, pharmaceuticals, electrical goods, edible oils, fats and spreads and nutritional products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.